Clinical implications of antimicrobial resistance

Antimicrobial Resistance in Asia: Current Epidemiology and Clinical Implications

Antimicrobial resistance has become one of the most serious public health concerns worldwide. Although circumstances may vary by region or country, it is clear that some Asian countries are epicenters of resistance, having seen rapid increases in the prevalence of antimicrobial resistance of major bacterial pathogens. In these locations, however, the public health infrastructure to combat this ...

Global antimicrobial resistance alerts and implications.

Clinical impact of antimicrobial resistance in animals.

It is almost impossible to imagine veterinary medicine today without the use of antimicrobials. Shortly after their discovery, antimicrobials found their way into the veterinary world. They have brought many benefits for the health and welfare of both animals and people, such as the lessening of pain and suffering, reduction in shedding of (zoonotic) bacteria and the containment of potentially ...

Clinical impact of antimicrobial resistance in humans.

The dramatic rise in the number and spread of resistant bacterial species continues. This involves not only bacteria that cause infections in the healthcare sector but also those that originate in the community. Antibiotic resistance rates are rising in almost all bacterial species, including those that are the most common bacterial pathogens in people (Escherichia coli and Staphylococcus aureu...

Clinical and economic implications of antimicrobial resistance for the management of community-acquired respiratory tract infections.

Lower respiratory tract infections (RTIs), particularly community-acquired pneumonia (CAP), account for over 50 million deaths annually worldwide. They place an extensive clinical and financial burden on healthcare authorities. Upper RTIs, usually mild and non-life threatening, also incur significant healthcare costs. The rising prevalence of resistance of the major causative agents of CAP (Str...